Literature DB >> 17395504

Genetic and clinical features of patients with Gaucher disease in Hungary.

Melinda Erdos1, Katerina Hodanova, Szilvia Taskó, Anita Palicz, Larisa Stolnaja, Lenka Dvorakova, Martin Hrebicek, László Maródi.   

Abstract

The aim of this study was to identify mutations in the gene encoding for lysosomal beta-glucocerebrosidase (GBA; gene symbol, GBA) in Hungarian patients with Gaucher disease (GD), and to study genotype-phenotype relationships. Genotypes and allele variations in 27 patients with type I GD of 25 unrelated families were studied. Of the 54 mutant alleles, we detected 38 frequent (N370S, 22/54; RecNciI, 8/54; L444P, 8/54) and 9 rare (N188S, R257Q, R285C, G377S, R120W, T323I, 84GG, 1263-1317del and 1263-1317del/RecTL) mutations. In addition, we identified two novel mutations. The N370S/RecNciI genotype found in 8 patients and the N370S/L444P genotype found in 5 patients were the most frequent genotypes in this cohort. In 22 patients the mutations occurred in heterozygosity with the N370S sequence variant, and one patient was homozygous for the L444P mutation. These data suggest that N370S, RecNciI, and L444P are the most prevalent mutations in Hungarian patients with GD. This mutation profile is characteristic for a Caucasian (non-Jewish) population. The c.260G>A and c.999G>A missense mutations are described here for the first time in GD patients contributing to the panel of reported GBA mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395504     DOI: 10.1016/j.bcmd.2007.02.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  6 in total

1.  Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case.

Authors:  Carmela Zizzo; Irene Ruggeri; Paolo Colomba; Christiano Argano; Daniele Francofonte; Marcomaria Zora; Emanuela Maria Marsana; Giovanni Duro; Salvatore Corrao
Journal:  Biology (Basel)       Date:  2022-06-15

2.  Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression.

Authors:  Nevenka Ridova; Sanja Trajkova; Biljana Chonevska; Zlate Stojanoski; Martin Ivanovski; Marija Popova-Labachevska; Simona Stojanovska-Jakimovska; Venko Filipche; Aspazija Sofijanova; Irina Panovska-Stavridis
Journal:  Mol Genet Metab Rep       Date:  2022-07-08

Review 3.  Gaucher disease: new developments in treatment and etiology.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

4.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

5.  Progressive myoclonus epilepsy in Gaucher Disease due to a new Gly-Gly mutation causing loss of an Exonic Splicing Enhancer.

Authors:  Rodolfo Tonin; Serena Catarzi; Anna Caciotti; Elena Procopio; Carla Marini; Renzo Guerrini; Amelia Morrone
Journal:  J Neurol       Date:  2018-10-31       Impact factor: 4.849

6.  Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece.

Authors:  Evangelia Dimitriou; Marina Moraitou; Mónica Cozar; Jenny Serra-Vinardell; Lluïsa Vilageliu; Daniel Grinberg; Irene Mavridou; Helen Michelakakis
Journal:  Mol Genet Metab Rep       Date:  2020-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.